Biotech Stocks Continue To See Premarket Buying Pressure

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, June 28, 2022

An Illinois-based biotech company is making waves during Tuesday’s premarket after the company annocued a new collaboration with Boehringer Ingelheim to identify biomarkers for inflammatory bowel disease, according to the release. This news sent shares of BioX Inc (NYSE American:PHGE) rallying strongly as we head into the final minutes before the opening bell.

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis.

As previously mentioned, traders appear to be bullish on the new collaboration news as shares are currently bid up at $0.8997/share (+23.25% implied open for sellers). This move would be a strong continuation of the recent success this stock has had over the last month.

Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.